AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022
Apr 1, 2022
30339_dirs_2022-04-01_dd7d6f8f-42e4-4ebb-b2a2-c5381d92a4d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-03-31
Reporting Person: ZENNER PATRICK J (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | Phantom Stock Unit | $ | A | 49.00 | Acquired | Common Stock (49.00) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 39974.29 | Direct |
Footnotes
F1: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27